Cargando…
Evaluation of prevalent and incident ovarian cancer co-morbidity
BACKGROUND: The peak in incidence of ovarian cancer occurs around 65 years and concurrent increasing risk by age for a number of diseases strongly influence treatment and prognosis. The aim was to explore prevalence and incidence of co-morbidity in ovarian cancer patients compared with the general p...
Autores principales: | Stålberg, K, Svensson, T, Granath, F, Kieler, H, Tholander, B, Lönn, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364567/ https://www.ncbi.nlm.nih.gov/pubmed/22549177 http://dx.doi.org/10.1038/bjc.2012.164 |
Ejemplares similares
-
Prenatal ultrasound and the risk of childhood brain tumour and its subtypes
por: Stålberg, K, et al.
Publicado: (2008) -
Prenatal X-ray exposure and childhood brain tumours: a population-based case–control study on tumour subtypes
por: Stålberg, K, et al.
Publicado: (2007) -
Breast cancer prognosis in relation to family history of breast and ovarian cancer
por: Thalib, L, et al.
Publicado: (2004) -
Family history of breast cancer and young age at diagnosis of breast cancer increase risk of second primary malignancies in women: a population-based cohort study
por: Prochazka, M, et al.
Publicado: (2006) -
Are lower rates of surgery amongst older women with breast cancer in the UK explained by co-morbidity?
por: Lavelle, K, et al.
Publicado: (2012)